7 months ago
1
Global pharmaceutical institution Pfizer has announced the motorboat of a Rimegepant Orally Disintegrating Tablet (ODT) successful India for acute attraction of migraine successful adults with a erstwhile insufficient effect to triptan.
“The caller medicine delivers accelerated and sustained symptom alleviation lasting up to 48 hours post-treatment, portion not associated with the hazard of medicine overuse headaches. It besides enables aboriginal instrumentality to relation and sustained alleviation from astir bothersome symptoms. Rimegepant volition beryllium disposable successful a 75 mg orally disintegrating tablet (ODT) form, designed for convenient medication without the request for water,’’ said a connection released by the Company.
It added that by targeting 1 of the cardinal elements of migraine’s pathophysiology – calcitonin gene-related peptide (CGRP) – this medicine offers punctual and effectual relief.
Meenakshi Nevatia, MD, Pfizer Ltd., India, said “We judge this attraction volition assistance radical with migraine negociate symptom much efficaciously and reclaim productive days sooner than with presently disposable options.”
